POLI:TASEBank Hapoalim BM Analysis

PB Fintech’s shares are currently trading at ₹1,467.9, which sits below the 20‑day SMA (~₹1,494) and the 50‑day SMA (~₹1,604), reinforcing a short‑term bearish bias. The RSI of 42 suggests the stock is not yet oversold, while the MACD histogram has turned positive, hinting at a tentative bullish momentum under the broader downtrend. Support is observed around ₹1,364 and resistance near ₹1,566, with volatility running at a steep 43% over the past 30 days and a slightly negative beta, implying heightened price swings and limited correlation to the market.
Fundamentally, the company posted a 37% revenue surge and a 165% YoY jump in PAT, driven by a 45% rise in total premium and strong health‑insurance growth. The forward‑PE of ~61, though still lofty compared with the industry average PE of 17, reflects expectations of accelerating earnings, especially after the announced $1 billion QIP fundraising aimed at bolstering balance‑sheet strength and fueling expansion into new segments.